Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroyoshi Takeuchi

Showing results (61-70 of 203) with videos related to

Pageof 21
Sort By:
Journal of Psychiatric Research|June 20, 2016
A preliminary examination of the validity and reliability of a new brief rating scale for symptom domains of psychosis: Brief Evaluation of Psychosis Symptom Domains (BE-PSD)Hiroyoshi Takeuchi, Gagan Fervaha, Jimmy Lee, et al.
The Journal of ECT|February 2, 2026
Electroconvulsive Therapy for Tardive Akathisia in a Patient With No Prior Psychiatric History: A Case ReportKyosuke Sawada, Tatsuya Kurokawa, Mari Iizuka, et al.
Journal of Psychiatric Research|January 16, 2017
Representativeness of clinical PET study participants with schizophrenia: A systematic reviewSo Kirino, Takefumi Suzuki, Hiroyoshi Takeuchi, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 15, 2014
Effect of antipsychotic medication on overall life satisfaction among individuals with chronic schizophrenia: findings from the NIMH CATIE studyGagan Fervaha, Ofer Agid, Hiroyoshi Takeuchi, et al.
Schizophrenia Research|September 26, 2021
Antipsychotic nonadherence measured by electronic adherence monitoring in stabilized chronic schizophrenia: Clinical implicationsHiroyoshi Takeuchi, Marcos Sanches, Carol Borlido, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 5, 2015
Effectiveness of different dosing regimens of risperidone and olanzapine in schizophreniaHiroyoshi Takeuchi, Gagan Fervaha, Jimmy Lee, et al.
CNS Drugs|June 28, 2026
Psychiatric Symptoms Associated with Corticosteroid Use: A Systematic Review and Meta-analysisKeisuke Kusudo, Yuki Mashima, Hideaki Yasuda, et al.
Journal of Clinical Psychopharmacology|July 14, 2009
Predictors of clinical worsening after a switch to aripiprazole in patients with schizophrenia: a 1-year naturalistic follow-up studyHiroyoshi Takeuchi, Hiroyuki Uchida, Takefumi Suzuki, et al.
Schizophrenia Research|December 14, 2020
Risk of withdrawal of consent for treatment with long-acting injectable versus oral antipsychotics: A meta-analysis of randomized controlled trialsHodaka Yaegashi, Fuminari Misawa, Hokuto Noda, et al.
Psychiatry and Clinical Neurosciences|December 9, 2009
Changes in metabolic parameters following a switch to aripiprazole in Japanese patients with schizophrenia: One-year follow-up studyHiroyoshi Takeuchi, Hiroyuki Uchida, Takefumi Suzuki, et al.
Pageof 21

Showing results (61-70 of 203) with videos related to

Sort By:
Pageof 21
Journal of Psychiatric Research|June 20, 2016
A preliminary examination of the validity and reliability of a new brief rating scale for symptom domains of psychosis: Brief Evaluation of Psychosis Symptom Domains (BE-PSD)Hiroyoshi Takeuchi, Gagan Fervaha, Jimmy Lee, et al.
The Journal of ECT|February 2, 2026
Electroconvulsive Therapy for Tardive Akathisia in a Patient With No Prior Psychiatric History: A Case ReportKyosuke Sawada, Tatsuya Kurokawa, Mari Iizuka, et al.
Journal of Psychiatric Research|January 16, 2017
Representativeness of clinical PET study participants with schizophrenia: A systematic reviewSo Kirino, Takefumi Suzuki, Hiroyoshi Takeuchi, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 15, 2014
Effect of antipsychotic medication on overall life satisfaction among individuals with chronic schizophrenia: findings from the NIMH CATIE studyGagan Fervaha, Ofer Agid, Hiroyoshi Takeuchi, et al.
Schizophrenia Research|September 26, 2021
Antipsychotic nonadherence measured by electronic adherence monitoring in stabilized chronic schizophrenia: Clinical implicationsHiroyoshi Takeuchi, Marcos Sanches, Carol Borlido, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 5, 2015
Effectiveness of different dosing regimens of risperidone and olanzapine in schizophreniaHiroyoshi Takeuchi, Gagan Fervaha, Jimmy Lee, et al.
CNS Drugs|June 28, 2026
Psychiatric Symptoms Associated with Corticosteroid Use: A Systematic Review and Meta-analysisKeisuke Kusudo, Yuki Mashima, Hideaki Yasuda, et al.
Journal of Clinical Psychopharmacology|July 14, 2009
Predictors of clinical worsening after a switch to aripiprazole in patients with schizophrenia: a 1-year naturalistic follow-up studyHiroyoshi Takeuchi, Hiroyuki Uchida, Takefumi Suzuki, et al.
Schizophrenia Research|December 14, 2020
Risk of withdrawal of consent for treatment with long-acting injectable versus oral antipsychotics: A meta-analysis of randomized controlled trialsHodaka Yaegashi, Fuminari Misawa, Hokuto Noda, et al.
Psychiatry and Clinical Neurosciences|December 9, 2009
Changes in metabolic parameters following a switch to aripiprazole in Japanese patients with schizophrenia: One-year follow-up studyHiroyoshi Takeuchi, Hiroyuki Uchida, Takefumi Suzuki, et al.
Pageof 21